EP3452514A1 - T-cell immunotherapy specific for mart-1 - Google Patents

T-cell immunotherapy specific for mart-1

Info

Publication number
EP3452514A1
EP3452514A1 EP17724686.5A EP17724686A EP3452514A1 EP 3452514 A1 EP3452514 A1 EP 3452514A1 EP 17724686 A EP17724686 A EP 17724686A EP 3452514 A1 EP3452514 A1 EP 3452514A1
Authority
EP
European Patent Office
Prior art keywords
amino acid
acid sequence
cell
seq id
comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP17724686.5A
Other languages
German (de)
French (fr)
Inventor
Aude CHAPUIS
Philip Greenberg
Thomas Schmitt
Cassian Yee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hutchinson Fred Cancer Research Center
Original Assignee
Hutchinson Fred Cancer Research Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201662333117P priority Critical
Application filed by Hutchinson Fred Cancer Research Center filed Critical Hutchinson Fred Cancer Research Center
Priority to PCT/US2017/031453 priority patent/WO2017193104A1/en
Publication of EP3452514A1 publication Critical patent/EP3452514A1/en
Application status is Pending legal-status Critical

Links